FDA Approved: NEUPRO — Supplemental Application (UCB, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for NEUPRO (rotigotine) submitted by UCB, Inc., resulting in an approved labeling update for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Restless Legs Syndrome

Drugs mentioned

• Neupro (rotigotine)

Snippet

SUPPL AP for NEUPRO (ROTIGOTINE)